{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:27:27Z","timestamp":1781047647851,"version":"3.54.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"DOI":"10.1093\/ehjcvp\/pvx013","type":"journal-article","created":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T07:08:01Z","timestamp":1493795281000},"page":"82-92","source":"Crossref","is-referenced-by-count":19,"title":["Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study"],"prefix":"10.1093","volume":"4","author":[{"given":"Hanna","family":"Fr\u00f6hlich","sequence":"first","affiliation":[{"name":"Department of Cardiology, Angiology and Pulmology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Henning","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Pulmology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"T\u00e4ger","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Pulmology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Schellberg","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Pulmology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Grundtvig","sequence":"additional","affiliation":[{"name":"Department of Medicine, Innlandet Hospital Trust Division Lillehammer, Lillehammer, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Goode","sequence":"additional","affiliation":[{"name":"Hull York Medical School, Castle Hill Hospital, Hull, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Corletto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Pulmology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Kazmi","sequence":"additional","affiliation":[{"name":"Hull York Medical School, Castle Hill Hospital, Hull, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torstein","family":"Hole","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway"},{"name":"Medical Clinic, Helse M\u00f8re and Romsdal HF, \u00c5lesund, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo A","family":"Katus","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Pulmology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Atar","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Oslo University Hospital, Ulleval and Institute of Clinical Sciences, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G F","family":"Cleland","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Royal Brompton and Harefield Hospitals, Imperial College, London, UK"},{"name":"Robertson Centre for Biostatistics and Clinical Trials, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Agewall","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Oslo University Hospital, Ulleval and Institute of Clinical Sciences, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Frankenstein","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Pulmology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L","family":"Clark","sequence":"additional","affiliation":[{"name":"Hull York Medical School, Castle Hill Hospital, Hull, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,5,5]]},"reference":[{"key":"key\n\t\t\t\t20180315055243_pvx013-B1","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B2","first-page":"e282","article-title":"ACC\/AHA\/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"134","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B3","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","article-title":"Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials","volume":"273","author":"Garg","year":"1995","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B4","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","author":"The CONSENSUS Trial Study Group","year":"1987","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"The SOLVD Investigators","year":"1991","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions","volume":"327","author":"The SOLVD Investigators","year":"1992","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B7","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","article-title":"Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group","volume":"100","year":"1999","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators","volume":"327","year":"1992","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B9","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B10","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B11","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/01.CIR.97.14.1411","article-title":"Angiotensin-converting enzyme inhibitors","volume":"97","author":"Brown","year":"1998","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B12","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1097\/00004872-199407030-00012","article-title":"Comparative trial of quinapril versus captopril in mild to moderate congestive heart failure. Quinapril\/Captopril Congestive Heart Failure Study Group","volume":"12","author":"Gavazzi","year":"1994","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B13","doi-asserted-by":"crossref","first-page":"70C","DOI":"10.1016\/0002-9149(92)91361-7","article-title":"Long-acting angiotensin-converting enzyme inhibition: once-daily lisinopril versus twice-daily captopril in mild-to-moderate heart failure","volume":"70","author":"Bach","year":"1992","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1067\/mhj.2003.24","article-title":"Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) study","volume":"145","author":"Borghi","year":"2003","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B15","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/0002-9149(94)90178-3","article-title":"Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the \u2018PRACTICAL\u2019 study)","volume":"73","year":"1994","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B16","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/0735-1097(89)90294-5","article-title":"Short- and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. The Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group","volume":"13","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B17","doi-asserted-by":"crossref","first-page":"e2554.","DOI":"10.1097\/MD.0000000000002554","article-title":"Comparison of the efficacy and safety of different ace inhibitors in patients with chronic heart failure: A PRISMA-compliant network meta-analysis","volume":"95","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Int Med"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/bimj.200810488","article-title":"Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations","volume":"51","author":"Austin","year":"2009","journal-title":"Biom J"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B20","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3692-2","volume-title":"Observational Studies","author":"Rosenbaum","year":"2002","edition":"2nd ed"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B21","volume-title":"Spreadsheet-based sensitivity analysis calculations for matched samples","author":"Love","year":"2008"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijcard.2014.12.092","article-title":"Use of different types of angiotensin converting enzyme inhibitors and mortality in systolic heart failure","volume":"182","author":"Svanstrom","year":"2015","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.amjcard.2004.08.097","article-title":"Comparison of angiotensin-converting enzyme inhibitors in the treatment of congestive heart failure","volume":"95","author":"Tu","year":"2005","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B24","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1503\/cmaj.060068","article-title":"Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure","volume":"178","author":"Pilote","year":"2008","journal-title":"CMAJ"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.7326\/0003-4819-141-2-200407200-00008","article-title":"Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect?","volume":"141","author":"Pilote","year":"2004","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.sapharm.2011.03.001","article-title":"Effect of certain angiotensin-converting enzyme inhibitors on mortality in heart failure: a multiple-propensity analysis","volume":"8","author":"Chitnis","year":"2012","journal-title":"Res Social Adm Pharm"},{"key":"key\n\t\t\t\t20180315055243_pvx013-B27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2217\/cer.12.5","article-title":"Comparative effectiveness of different angiotensin-converting enzyme inhibitors on the risk of hospitalization in patients with heart failure","volume":"1","author":"Chitnis","year":"2012","journal-title":"J Comp Eff Res"}],"container-title":["European Heart Journal - Cardiovascular Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjcvp\/article-pdf\/4\/2\/82\/24260509\/pvx013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T05:52:51Z","timestamp":1521093171000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article\/4\/2\/82\/3798743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,5]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,5,5]]},"published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcvp\/pvx013","relation":{},"ISSN":["2055-6837","2055-6845"],"issn-type":[{"value":"2055-6837","type":"print"},{"value":"2055-6845","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2017,5,5]]}}}